GLP-1 drugs and bad breath: what's actually causing it

What did @bossl8t actually say?

The creator is asking a crowd-sourced question, not making a medical claim, and credit goes to them for being upfront about that. They describe burps that smell "horrible" since starting GLP-1 medications, first semaglutide, now tirzepatide. Their grandkid thought they passed gas. They want to know if other users are experiencing the same thing and whether the drug type matters.

This is anecdotal, but it reflects a real and widely reported side effect pattern. The creator isn't diagnosing anything or selling a solution. They're doing what millions of GLP-1 users do: trying to make sense of something their body is doing that nobody warned them about. That framing matters when evaluating what they got right.

Does the science back this up?

Yes, actually. Sulfur burps are a legitimate, documented side effect of GLP-1 receptor agonists, and the mechanism isn't mysterious. GLP-1 drugs slow gastric emptying, which means food, particularly protein, sits in your stomach longer than usual. That extended fermentation produces hydrogen sulfide gas. That is what smells like rotten eggs.

A 2023 FDA adverse event report analysis published in JAMA Internal Medicine (Sodhi et al., 2023) confirmed that gastrointestinal side effects including eructation (the clinical word for burping) are significantly more common with semaglutide than with other weight-loss interventions. The slowed gastric emptying effect is well-established in clinical pharmacology literature going back to early GLP-1 studies (Nauck et al., 2011, Diabetes Care). The smell is not imaginary, and it is not rare. Online communities for semaglutide and tirzepatide users are full of identical complaints, which aligns with the mechanism.

What did they get wrong (or right)?

They got the core observation right. Where things get murkier is the implicit suggestion that this might differ between semaglutide and tirzepatide. The creator asks commenters to specify which drug they're on, hinting at a difference. That's an interesting hypothesis but there's no published clinical trial directly comparing sulfur burp frequency between the two drugs.

Tirzepatide targets both GIP and GLP-1 receptors, making it a dual agonist, and its effects on gastric motility may differ in degree from semaglutide. A 2022 trial in The New England Journal of Medicine (Jastreboff et al., SURMOUNT-1) documented higher rates of nausea and GI events with tirzepatide at higher doses compared to placebo, but head-to-head GI comparisons with semaglutide are limited. So the creator is asking a reasonable clinical question that science hasn't fully answered yet. That's not a flaw in their reasoning. It's a gap in the research.

What should you actually know?

If you're on a GLP-1 drug and your burps smell bad, you are not alone and you are not imagining it. The slowed gastric emptying that makes these drugs effective for weight loss is the same mechanism creating that smell. A few things are worth knowing. High-protein diets, which many GLP-1 users adopt, can worsen hydrogen sulfide production. Eating smaller meals, chewing thoroughly, and avoiding carbonated drinks may reduce the frequency.

Some clinicians recommend probiotics or digestive enzymes as adjunct support, though evidence for these specifically in GLP-1 users is limited. If burping is accompanied by significant abdominal pain, vomiting, or feels like it is getting worse over time rather than stabilizing, that warrants a conversation with a prescriber. Gastroparesis, a more serious delay in stomach emptying, has been flagged in post-market GLP-1 case reports and should not be dismissed as just a burp problem if symptoms are severe.

• Sulfur burps are caused by delayed gastric emptying, not a random drug quirk.
• High-protein intake worsens hydrogen sulfide gas production in the stomach.
• Eating smaller, slower meals can reduce symptom frequency.
• Severe or worsening GI symptoms should be reported to a prescriber.

Bottom line

@bossl8t described a real pharmacological side effect using a car-ride analogy instead of clinical language. Both are valid. The mechanism is understood, the experience is common, and the question about whether semaglutide versus tirzepatide produces worse smells is genuinely unanswered by current literature. If your doctor put you on one of these medications and didn't mention this possibility, that is a gap in patient counseling worth raising at your next visit.